Comparative bioavailability of diltiazem in prolonged-release oral preparations

Drug Development and Industrial Pharmacy

Volumn 27, Issue 10, 2001, Pages 1099-1106

  Quiroga, P A M ^a   Yuln, G V ^a   Palummo, M ^a   Cingolani, A ^a   Dall, L L ^a   Volonte M G ^a  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

Author keywords

Bioavailability; Bioequivalence; Diltiazem; Matrix hydrophilic

Indexed keywords

DILTIAZEM;

ARTICLE; BIOEQUIVALENCE; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; SUSTAINED RELEASE PREPARATION;

ADMINISTRATION, ORAL; ADULT; BIOLOGICAL AVAILABILITY; CALCIUM CHANNEL BLOCKERS; CAPSULES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DILTIAZEM; FEMALE; HUMANS; MALE; MIDDLE AGED; SOLUBILITY; TABLETS, ENTERIC-COATED;

EID: 0035680447     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100108372     Document Type: Article

References (18)

1. Alternatives to traditional antihypertensive therapy
2. High-Performance liquid chromatographic determination of diltiazem and two of its metabolites in plasma using a short alkyl chain deactivated column
3. High-Performance liquid chromatographic assay of diltiazem and six of its metabolites in plasma: Application to a pharmacokinetic study in healthy volunteers
4. Liquid chromatographic determination of diltiazem and its metabolites using trans isomers as internal standards, with dynamic modification of the solid phase by addition an amine to the mobile phase
5. Bioavailability of diltiazem as a function of the administered
6. Metodologia analitica pot HPLC aplicada al monitoreo de diltiazem en plasma
7. Análisis farmacocinético de una nueva forma farmacéutica de diltiazem
8. Niveles plasmaticos de diltiazem A.P. en pacientes cardiopatas de 3era. edad en tratamiento continuo
9. The Concept of Dissolution Efficiency
10. In vitro/in vivo correlation of dissolution using moments of dissolution and transit times
11. max for absorption rates in investigations of bioequivalence
12. max/AUC in investigations of bioequivalence
13. In vivo determination of zero-order absorption from a transdermal glycerol trinitrate system
14. max for detecting differences in in vivo dissolution rates
15. The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time
16. Statistical design and evaluation of tests for bioavailability
17. Kinetic analysis of blood levels and urinary excretion in the absorptive phase after single doses of drug